UVA Engineers Design Lookalike Drug Nanocarrier to Treat Lung Diseases

Date posted
Funding Agency
(Funded by the National Institutes of Health and the National Science Foundation)

Engineers at the University of Virginia have created a drug nanocarrier designed to cure chronic or deadly respiratory diseases by slipping past the lungs' natural defenses. The engineers successfully demonstrated the nanocarrier's effectiveness using a device that captures the geometric and biological features of human airways. "We think this innovation not only promises better treatments of lung diseases with reduced side effects, but also opens possibilities for treating conditions affecting mucosal surfaces throughout the body," said Liheng Cai, one of the engineers involved in this study.

Keywords